Co-Authors
This is a "connection" page, showing publications co-authored by Matthew Hall and Kyle Brimacombe.
Connection Strength
0.681
-
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit. J Infect Dis. 2021 Jul 15; 224(Supplement_1):S1-S21.
Score: 0.239
-
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19. ACS Cent Sci. 2020 06 24; 6(6):1009.
Score: 0.222
-
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. ACS Cent Sci. 2020 May 27; 6(5):672-683.
Score: 0.220